Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Alfuzosin for the Treatment of Non-neurogenic Voiding Dysfunction in Female: An 8 Week Prospective, Randomized Double Blind, Placebo-Controlled, Parallel Group Study (Phase Ⅱ)

NCT00679315 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT00679315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00679315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Alfuzosin for the Treatment of Non-neurogenic Voiding Dysfunction in Female: An 8 Week Prospective, Randomized Double Blind, Placebo-Controlled, Parallel Group Study (Phase Ⅱ)
Lead sponsor
Samsung Medical Center
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2008
Completion date
December 31, 2009
Enrollment
190 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

voiding dysfunction